瑞亚力

4000-888-086

info@canlee.com

中文版 English

投资者关系
INVESTOR RELATIONS
All categories
Homepage
/
History
/
2014

2014

  • Categories:History
  • Author:
  • Origin:
  • Time of issue:2021-11-27 21:31
  • Views:

(Summary description)Ruiyali Technology Co., Ltd. was established with a registered capital of 9.21 million RMB, focus on sheep polyclonal.

2014

(Summary description)Ruiyali Technology Co., Ltd. was established with a registered capital of 9.21 million RMB, focus on sheep polyclonal.

  • Categories:History
  • Author:
  • Origin:
  • Time of issue:2021-11-27 21:31
  • Views:
Information

 

Scan the QR code to read on your phone

Previous: 2015
Next: None
Previous: 2015
Next: None
There is currently no information to display
Please add data record on website background.

热点新闻

SIATER said | Su Shaobo: Choosing to start a business is to choose a life that is not arranged

SIATER said | Su Shaobo: Choosing to start a business is to choose a life that is not arranged

There is such a company that started in a small county in Shanxi six years ago. From the initial sales of 500,000 yuan to the present company’s annual sales of more than 50 million yuan, biological antibody products are exported to the United States, Britain, Germany, South Korea, Japan, and Ireland. In developed countries, it was the first Chinese company that invented droplets to generate oil, and the first company to successfully synthesize an amylase substrate to break the monopoly of Roche. This company engaged in the research and development and production of the core raw materials of in vitro diagnostic reagents is called Ruiyali Group. The head of the company is Su Shaobo, a senior engineer from Shenzhen Advanced Institute.
发布时间 : 2021-07-23 点击 : 0
A brief analysis of the commercial situation of China

A brief analysis of the commercial situation of China's in vitro diagnostic reagent raw material enterprises

By introducing the current status and pain points of the in vitro diagnostic reagent raw material industry in China, it analyzes and thinks about the current status of the in vitro diagnostic reagent market, and points out the future industry development direction and looks forward to the future.
发布时间 : 2021-07-19 点击 : 0
Ruiali Group signed a contract to move into Shenzhen Pingshan Comprehensive Bonded Zone!

Ruiali Group signed a contract to move into Shenzhen Pingshan Comprehensive Bonded Zone!

On May 24, 2020, the State Council approved the integration and optimization of Guangdong Shenzhen Export Processing Zone into Shenzhen Pingshan Comprehensive Bonded Zone. According to the relevant requirements of the "Letter of the General Administration of Customs on the Planning and Construction of Shenzhen Pingshan Comprehensive Bonded Zone" (Shou Maohan [2020] No. 154), Shenzhen Pingshan Comprehensive Bonded Zone shall apply to the General Administration of Customs for acceptance within one year from the date of approval of the establishment of the State Council .
发布时间 : 2021-06-26 点击 : 0
TOP
Online Message
SEARCH
OK
cancel
瑞亚力集团

Building 1, shenfubao science and Technology Ecological Industrial Park, No. 18, Jinxiu West Road, Laokeng community, Longtian street, Pingshan District, Shenzhen

501, building B1, jinweiyuan industrial plant, JuLongshan District, Zhukeng community, Longtian street, Pingshan District, Shenzhen

Copyright © 2021 Shenzhen Realbiogroup Co.,Ltd   ICP备**********-1号